Meeting Reports | CGRP Education & Research Forum - Part 6

CGRP Forum is made possible thanks to support from AbbVie, Lilly, Organon and Pfizer, all of whom have no influence or control of editorial content. More information is available here »

Positive data reported for eptinezumab in Sunrise trial New insights on treatment holidays with erenumab Dual CGRP ligand mAb and gepant therapy reduces headache severity CGRP-mAb switching yields migraine day reduction Lower switching rates with atogepant than CGRP mAbs EMBRACE shows erenumab reduces migraine severity Older patients benefit from CGRP mAbs too DELIVER shows long term QoL benefits with eptinezumab

20th Migraine Trust International Symposium 2024

The 20th Migraine Trust International Symposium was held from 5-8 September 2024 in London, UK, and online

10th European Academy of Neurology Congress 2024

Over 9,000 delegates registered for in-person or online attendance at this year's European Academy of Neurology Congress in Helsinki, Finland (29 June-2 July 2024), with headache presentations including extensive real world data on use of anti-CGRP therapies, together with latest insights into their effects on the migraine brain

66th Annual Scientific Meeting of the American Headache Society 2024

Reports from this year’s annual scientific meeting of the American Headache Society in San Diego, USA, and online (13-16 June 2024), include recent progress towards precision medicine for migraine, concerning data about patient groups that miss out on anti-CGRP therapies, CGRP mAb trial results in cluster headache, and cortical changes following CGRP mAb therapy.

76th American Academy of Neurology Annual Meeting 2024

At AAN2024, delegates met in Denver, USA, and online from 13-18 April, for presentations across the spectrum of neurology, including latest research on the efficacy, safety and current prescribing patterns for anti-CGRP therapy.

17th European Headache Congress 2023

The 17th European Headache Congress was held in Barcelona, Spain, and online, on 6-9 December 2023, with the theme of ‘Headache: Expanding the Horizon'.

XXVI World Congress of Neurology 2023

The XXVI World Congress of Neurology (WCN 2023) took place in Montreal, Canada and online between 15-19 October.

International Headache Congress 2023

At this year’s International Headache Congress, migraine specialists from around the world gathered in Seoul, Republic of Korea (14-17 September), and online, to discuss latest research.

9th EAN Congress 2023

More than 7700 delegates registered for this year's European Academy of Neurology Congress (1-4 July), with three quarters attending in person in Budapest, Hungary.

65th Annual Scientific Meeting of the American Headache Society 2023

This year's annual scientific meeting was held in Austin, Texas (15-18 June 2023), with participants attending in-person and online.

75th American Academy of Neurology Annual Meeting 2023

This year’s Annual Meeting was held live in Boston, USA, from 22-28 April, with delegates meeting in person and online for presentations on the latest clinical and scientific data including research on anti-CGRP therapies.

16th European Headache Congress 2022

The 16th European Headache Congress was held in Vienna, Austria, and online, on 7-10 December 2022, with the theme of 'Moving to a Headache-less Future'.

Migraine Trust International Symposium 2022

The 19th Migraine Trust International Symposium was held from 8-11 September 2022 in London, UK, with on-demand access available until Monday, 12 December 2022.

8th Congress of the European Academy of Neurology 2022

Over 5000 delegates attended this year's European Academy of Neurology congress in Vienna, Austria (25-28 June), and nearly 3000 joined online.

64th Annual Meeting of the American Headache Society 2022

On 9-12 June 2022, this year’s congress was held in Denver, Colorado, as both an in-person and as a virtual experience.

American Academy of Neurology 2022

This year's Annual Meeting was held live in Seattle, USA, from 2-7 April, with delegates meeting in person for presentations on the latest clinical and scientific data including research on anti-CGRP therapies.

XXV World Congress of Neurology 2021

The World Congress of Neurology 2021, due to be held in Rome, Italy, was held virtually on 3-7 October 2021, with the theme of "Inspired by the Past to build the Future of Neurology".

International Headache Congress 2021

The Joint Congress of the International Headache Society and the European Headache Federation was held online from 8-12 September 2021 with the theme of Headache Science to Optimise Patient Care.

7th Congress of the European Academy of Neurology 2021

More than 11,000 delegates joined this year's Virtual EAN Congress from 19-22 June 2021. EAN members can catch up on sessions they missed through the extensive videos of presentations and discussions on the EAN website.

63rd Annual Meeting of the American Headache Society 2021

This year's congress was held as a virtual meeting on 3-6 June 2021 featuring live-streamed sessions, live Q&A and pre-recorded lectures available on demand.

American Academy of Neurology 2021 Virtual Annual Meeting

Due to the continuing COVID-19 pandemic, the 2021 AAN Annual Meeting was held in a fully virtual format from April 17-22.

Migraine Trust International Symposium 2020

This year's Virtual Symposium was held on 3-9 October 2020 and included live and on-demand lectures, training courses, industry symposia and poster presentations.

14th European Headache Federation Congress 2020

At this year's virtual meeting, registered participants were able to watch live and pre-recorded sessions, including presentations and discussions.

62nd Annual Meeting of the American Headache Society 2020

This year's congress was held as a virtual meeting with content available online to registered participants for 12 months.

6th Congress of the European Academy of Neurology 2020

Over 42,000 delegates from across the globe registered to attend the European Academy of Neurology Virtual Meeting, 23-26 May 2020, making it the largest ever neurology congress.

American Academy of Neurology 2020

Although the congress was cancelled due to COVID-19, we report highlights of accepted abstracts on CGRP therapies

World Congress of Neurology 2019

Dubai, United Arab Emirates, 27 - 31 October 2019

IHC 2019

Dublin, Ireland, 5-8 September 2019

American Headache Society (AHS) 61st Annual Scientific Meeting 2019

Philadelphia, USA, 11 – 14 July 2019

5th Congress of the European Academy of Neurology 2019

Oslo, Norway, 29 June - 2 July 2019

13th European Headache Federation Congress 2019

Athens, Greece, 30 May - 1 June 2019

American Academy of Neurology Annual Meeting 2019

Philadelphia, USA, 4-10 May 2019

12th European Headache Federation Congress 2018

Florence, Italy, 28-30 September 2018

17th Biennial Migraine Trust International Symposium 2018

London, UK, 6-9 September 2018

American Headache Society (AHS) 60th Annual Scientific Meeting 2018

San Francisco, USA, 27 June - 1 July 2018

4th Congress of the European Academy of Neurology 2018

Lisbon, Portugal, 16-19 June 2018

American Academy of Neurology (AAN) Congress 2018

Los Angeles, USA, 21-27 April 2018

11th European Headache Federation Congress 2017

Rome, Italy, 1-3 December 2017

18th Congress of the International Headache Society 2017

Vancouver, Canada, 7-10 September 2017

American Headache Society Annual Scientific Meeting 2017

Boston, USA, 8-11 June 2017

3rd Congress of the European Academy of Neurology 2017

Amsterdam, The Netherlands, 24-27 June 2017

American Academy of Neurology Annual Meeting 2017

Boston, USA, 22-28 April 2017

Scottsdale Headache Symposium 2016

Scottsdale, Arizona, 17-20 November 2016

The European Headache and Migraine Trust International Congress (EHMTIC) 2016

Glasgow, 15-18 September 2016

Educational Partners and Supporters

This program is funded in part via an independent educational grant from AbbVie.

Organon has provided sponsorship towards this independent resource. Organon has had no editorial input or control over content, nor opportunity to influence.

Financial support was provided as GMG Knowledge Gap Grant from Pfizer Inc, Pfizer have provided only financial support and had no input into the content provided.

Editorial PolicyCGRP Forum is an expert resource for clinicians and healthcare professionals working with migraine patients. All patients should discuss their medication with their healthcare professional. Unless otherwise indicated, opinions expressed in the CGRP Education and Research Forum are those of the contributors. Although every effort is made to ensure accuracy and avoid mistakes, no liability on the part of the CGRP Forum, the editors or the editorial board is accepted for the consequences of any misleading or inaccurate information.

© 2024 | Privacy Policy | Editorial Policy | Governance | Disclaimer Statement | Partnership & Outreach | Educational Partners and Supporters |